Metronidazole-induced encephalopathy in a patient with Crohn's disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Chun, J. | - |
dc.contributor.author | Park, J.Y. | - |
dc.contributor.author | Hong, S.W. | - |
dc.contributor.author | Lee, J.Y. | - |
dc.contributor.author | Kang, J.W. | - |
dc.contributor.author | Hwang, S. | - |
dc.contributor.author | Ko, S.-B. | - |
dc.contributor.author | Im, J.P. | - |
dc.contributor.author | Kim, J.S. | - |
dc.date.accessioned | 2024-01-31T04:30:44Z | - |
dc.date.available | 2024-01-31T04:30:44Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1598-9100 | - |
dc.identifier.issn | 2288-1956 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71626 | - |
dc.description.abstract | Metronidazole is a widely used antibiotic for the treatment of anaerobic bacterial infections. Metronidazole-induced encephalopathy (MIEP) is a rare but potentially reversible disease. The mechanism of MIEP remains unclear, and differences in the neurotoxic effects of oral versus intravenous (IV) metronidazole administration have not yet been determined. We report the case of a Crohn's disease (CD) patient who experienced encephalopathy immediately after a single IV dose of metronidazole following long-term exposure to the oral form of the drug. The 64-year-old man with intractable CD experienced a sudden change in mental status, aphasia, and muscle weakness after IV administration of metronidazole. He had previously taken metronidazole orally for 13 years and received intermittent IV metronidazole treatments for CD exacerbation. Brain magnetic resonance imaging (MRI) showed high-intensity signals in the bilateral medial thalamus and the midbrain and pontine tegmentum on fluid-attenuated inversion recovery images. After discontinuation of metronidazole, the high-intensity brain MRI signals resolved and the patient's mental status dramatically improved; however, the patient exhibited mild cognitive dysfunction 2 months after the onset of encephalopathy. © 2017. Korean Association for the Study of Intestinal Diseases. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Association for the Study of Intestinal Diseases | - |
dc.title | Metronidazole-induced encephalopathy in a patient with Crohn's disease | - |
dc.type | Article | - |
dc.identifier.doi | 10.5217/ir.2017.15.1.124 | - |
dc.identifier.bibliographicCitation | Intestinal Research, v.15, no.1, pp 124 - 129 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85012969627 | - |
dc.citation.endPage | 129 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 124 | - |
dc.citation.title | Intestinal Research | - |
dc.citation.volume | 15 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Crohn disease | - |
dc.subject.keywordAuthor | Drug side effects | - |
dc.subject.keywordAuthor | Metabolic encephalopathy | - |
dc.subject.keywordAuthor | Metronidazole | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.